Oligoarticular juvenile idiopathic arthritis among Saudi children

沙特阿拉伯儿童少关节型幼年特发性关节炎

阅读:1

Abstract

BACKGROUND AND OBJECTIVES: Oligoarticular juvenile idiopathic arthritis (JIA) is the most frequent chronic inflammatory rheumatic condition in children. We aimed to describe the clinical and serological profile of Saudi patients with oligoarticular JIA. DESIGN AND SETTINGS: Hospital-based retrospective chart review of all children diagnosed with oligoarticular JIA and followed up at King Abdulaziz University Hospital between 1998 and 2012. PATIENTS AND METHODS: We reviewed the medical files of children with oligoarticular JIA and recorded the gender, age at presentation and diagnosis, clinical presentation, laboratory and radiological investigations, treatment administered, and disease complications. Descriptive statistics was performed using SPSS (version 20, SPSS Inc., Chicago, IL, USA). RESULTS: We enrolled 37 patients with JIA, of which 24 (64.9%) were girls. The mean age of the patients at presentation was 6.9 years, while the mean age at diagnosis was 7.2 years. A total of 31 patients (83.8%) presented with joint pain, and 36 (97.3%) had a swelling; 19 patients (51.4%) had a high erythrocyte sedimentation rate (ESR) at first presentation (mean, 41.8 [25.4] mm/h). ANA was positive in 15 patients (40.5%). The following treatments were administered: naproxen in 37 patients (100%), intra-articular corticosteroids in 12 cases (32.4%), methotrexate in 14 patients (37.8%), and adalimumab in 5 patients (13.5%). During follow-up, the following were documented: limited range of motion (n=15; 40.5%), deformity (n=5.4%), contracture (n=1; 2.7%), leg-length discrepancy (n=9; 24.3%), and anemia (n=7; 18.9%). CONCLUSION: Oligoarticular JIA is more frequent in females, and it shows a predilection for the knees. Initially, many patients presented with high ESRs, and they were antinuclear antibody positive. Early diagnosis and aggressive treatment resulted in a low rate of arthritis and extra-articular manifestations in our cohort.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。